Vol 2023, No 1 (2023)

Table of Contents

Research & Development

Moderna Signs US$1.2 B Collaboration with Oncology Specialist CytomX Abstract pdf html
Lucy Haggerty
AbbVie Partners with Immunome and Anima in Oncology-Focused Deals Abstract pdf html
Lucy Haggerty

Opinion & Analysis

Early Signs of M&A Activity Heating Up in 2023 Abstract pdf html
Lucy Haggerty


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.